Ixchiq
FDA Suspends License for Ixchiq Chikungunya Vaccine
The FDA suspended the license for the live-attenuated chikungunya vaccine, citing reports of serious adverse events ...
AUGUST 26, 2025
FDA Lifts Pause on Ixchiq Chikungunya Vaccine in People 60 and Up
The Ixchiq chikungunya vaccine is now available for people 60 years of age and older, after the FDA had paused all ...
AUGUST 7, 2025
AE Reports Prompt FDA, CDC to Hit Pause on Ixchiq Vaccine
The FDA and CDC recently issued a joint advisory statement recommending a pause in the use of the Ixchiq ...
MAY 15, 2025
The FDA Approves Ixchiq Chikungunya Vaccine
The FDA approved a single-dose, live-attenuated chikungunya virus (CHIKV) vaccine (Ixchiq, Valneva) to prevent the ...
NOVEMBER 13, 2023
Load more